StonvexLoading…
StonvexStonvexStonvexCore line items from IMOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $692.16M | $697.46M | $765.28M | $987.75M |
Operating Income | $38.85M | $62.33M | $104.68M | $200.52M |
Net Income | $43.90M | $64.26M | $111.93M | $177.98M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $1.38B | $1.51B | $1.46B | $1.53B |
Total Liabilities | $621.42M | $698.80M | $660.71M | $662.60M |
Cash & Equivalents | $464.14M | $403.46M | $322.05M | $212.91M |
Free Cash Flow OCF − CapEx | $26.21M | $115.40M | $127.47M | $51.84M |
Shares Outstanding | 727.24M | 727.24M | 727.24M | 727.24M |